Plain-English translation of NCT06776458 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Aromatase inhibitors are the most common hormone therapy used to treat hormone-positive breast cancer. This study is looking at how aromatase inhibitor therapy affects heart and blood vessel health over the long term—specifically checking whether the medication changes how the heart and vessels function and structure as time goes on. Researchers will compare women who took this medication 1, 5, or 10 years ago to similar women who never had cancer.
We know this medication is linked to a higher risk of heart problems, but we don't yet understand exactly how it damages the heart and blood vessels over time. This study will help doctors understand what changes happen in the body and which warning signs to look for early, so we can better protect breast cancer survivors' heart health.
You likely qualify if…
You likely don't qualify if…
You would come for one study visit where researchers will perform several tests to check your heart and blood vessel health. These tests include heart imaging, blood pressure checks, blood work, tests of how your vessels respond to position changes, and cognitive (thinking) tests. The visit may also include questions about your diet, activity level, and lifestyle. You will be matched with a woman of similar age and weight who did not have cancer so researchers can compare your results.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Canada